COVID-19 mRNA vaccine-mediated antibodies in human breast milk and their association with breast milk microbiota composition/Experiment 5

From BugSigDB


Reviewed Marked as Reviewed by ChiomaBlessing on 2024-2-15

Curated date: 2023/10/24

Curator: Folakunmi

Revision editor(s): Folakunmi, ChiomaBlessing

Subjects

Location of subjects
China
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Breast , Milk Mamma,Mammary part of chest,Mammary region,Breast,breast,Mammary gland milk,Milk,milk
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Response to vaccine Response to vaccine,response to vaccine
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Mothers at pre-vaccination timepoint (baseline)
Group 1 name Corresponds to the case (exposed) group for case-control studies
Mothers at one week post-second dose
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Breastfeeding mothers at one week post-second dose of BNT162b2 vaccine.
Group 0 sample size Number of subjects in the control (unexposed) group
44
Group 1 sample size Number of subjects in the case (exposed) group
43
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
None

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V3-V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
LEfSe
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
No
LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
1.5

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged
Chao1 Abundance-based estimator of species richness
unchanged

Signature 1

Reviewed Marked as Reviewed by ChiomaBlessing on 2024-2-15

Curated date: 2023/10/24

Curator: Folakunmi

Revision editor(s): Folakunmi, ChiomaBlessing

Source: supplementary table 3

Description: differential abundance of mothers at one week post second dose of BNT162b2 when compared to baseline.

Abundance in Group 1: increased abundance in Mothers at one week post-second dose

NCBI Quality ControlLinks
Acinetobacter baumannii
Acinetobacter soli
Acinetobacter ursingii
Brevundimonas olei
Epilithonimonas hominis
Moraxella atlantae
Moraxella porci
Paenibacillus macerans
Peredibacter starrii
Prevotella melaninogenica
Roseomonas gilardii
unclassified Acinetobacter
unclassified Actinobacillus
unclassified Brevundimonas
unclassified Chitinophagaceae
unclassified Gemmobacter
unclassified Gordonia (in: high G+C Gram-positive bacteria)
unclassified Klebsiella
unclassified Leptotrichia
unclassified Megamonas
unclassified Nautella
unclassified Neptunomonas
unclassified Ochrobactrum
unclassified Paracoccaceae
unclassified Peptoniphilus
unclassified Serratia (in: enterobacteria)
unclassified Vogesella
uncultured Clostridia bacterium
uncultured Paraburkholderia sp.
Clostridiales bacterium
unclassified Eubacterium (in: firmicutes)
unclassified Pseudarcobacter
unclassified Sandaracinobacter

Revision editor(s): Folakunmi, ChiomaBlessing

Signature 2

Reviewed Marked as Reviewed by ChiomaBlessing on 2024-2-15

Curated date: 2024/02/15

Curator: ChiomaBlessing

Revision editor(s): ChiomaBlessing

Source: Supplementary Table 3

Description: Differential abundance of mothers one week after second dose of BNT162b2 when compared to baseline.

Abundance in Group 1: decreased abundance in Mothers at one week post-second dose

NCBI Quality ControlLinks
Anaerococcus nagyae
Anaerococcus octavius
Arthrobacter russicus
Bacteroides caecimuris
Phocaeicola plebeius
Phocaeicola vulgatus
Clostridiaceae bacterium
unclassified Oscillospiraceae
Cutibacterium granulosum
Helicobacter rodentium
Ligilactobacillus aviarius
Pseudoxanthomonas kaohsiungensis
Rothia sp. (in: high G+C Gram-positive bacteria)
unclassified Eubacterium
unclassified A0389unclassified A0389
unclassified Akkermansia
unclassified Alcaligenes
unclassified Allobaculum
unclassified Bacilli
unclassified Bacteroides
unclassified Castellaniella
unclassified Bacillota
unclassified Colidextribacter
unclassified Coriobacteriaceae
unclassified Desulfovibrionaceae
unclassified Dubosiella
unclassified Faecalibacterium
unclassified Haliangium
unclassified Halomonadaceae
unclassified Halomonas
unclassified Kurthia
unclassified Lachnospiraceae
unclassified Lactobacillus
unclassified Muribaculaceae
unclassified Parabacteroides
unclassified Parasutterella
unclassified Peptostreptococcaceae
unclassified Prevotellaceae
unclassified Quinella
unclassified Ralstonia
unclassified Romboutsia
unclassified SUP05_clusterunclassified SUP05_cluster
unclassified Sutterella
unclassified Treponema
unclassified Turicibacter
uncultured Odoribacter sp.

Revision editor(s): ChiomaBlessing